• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Titans with Nathaniel Morris of PeyoteLab.com

Microdose by Microdose
February 3, 2022
in Psychedelic Titans
Reading Time: 5 mins read
A A
Psychedelic Titans with Nathaniel Morris of PeyoteLab.com

This week’s Psychedelic Titan is Nathaniel Morris, Peyote horticulturist and researcher for PeyoteLab.com.

What’s this article series about? Psychedelic Titans is a get-to-know-you-style blog series interviewing some of the psychedelic industry’s most influential and impactful individuals.

When did you first become involved in the psychedelic industry and why?

I’m 40 and have been in the cannabis/psychedelic space my entire career. I grew up in Canada, and I became a botany and mycology geek very young. I was already cultivating cannabis the first time I grafted peyote when I was 14. I ended up moving to Northern California and focusing my research on rare cannabinoids during my 20s and early 30s.

It wasn’t until my mid-30s that I realized that the same methods I’ve been using to study the cannabis entourage could be repurposed to study the peyote entourage.  When I moved back to Canada, I started PeyoteLab.com and began bioprospecting for ethically sourced, location-specific varieties of peyote with distinctive chemotypes.   I’m now working with these chemotypes to better understand their distinct properties.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Do you, or have you taken, psychedelic substances?

Yes, I think you have to if you want to study them properly. When I was younger, I used to explore these substances a lot.  Now I only like to microdose from time to time.  I think that personal experience is vital for research because it imparts a familiarity with the subtleties of these experiences.

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

I like the term mesearch to refer to this type of self-focused research.  Mesearch, or autoethnography, is when someone uses their personal experiences to tackle scientific questions. It is undeniable that nearly all of the great advances in the psychedelic space have come from people who were engaged in mesearch. Now that biometric sensors are widely available, it is easier than ever to explore plant medicines using scientific principles and methodologies.

What’s your favourite psychedelic compound?

Peyote is hands down my favorite! Although, technically speaking, the peyote entourage contains 50+ active components.  If ethically sourced peyote was not rare and expensive, I think almost everyone would prefer it over the other psychedelic options.  The closest thing I can describe it to is like if mushrooms and MDMA had a baby, only peyote is better than both.

The thing I like best about peyote is the diversity of chemotypes.  Location-specific varieties can have very different ratios of active constituents.  This is also true of cannabis, where two specimens of the same species can have very different medical properties.  This means I’m not studying one drug, I’m studying the differences between dozens of chemotypes producing various combinations of 50+ drugs.  A challenge like that requires biometrics, machine learning, and advanced analytical chemistry. It’s really a lot of fun.

Do your parents/family members know what you’re doing?

My whole family is enthusiastically supportive. My wife has also spent her entire adult life in the cannabis industry.  Both cannabis and peyote are perfectly legal in Canada, so there is nothing scandalous about working with plant medicines anymore.

When I was a kid, my parents were not happy about some of the plant and mushroom species I collected.  I am very dyslexic and struggled to learn to read as a teenager. To their credit, my parents could see that my interest in botany and mycology was positive, even if the species I took an interest in were sometimes problematic.

Have you had an experience with mental health/chronic pain?

I’m fortunate not to have personal experience with these issues.  However, I’ve seen these plant medicines do amazing things for people I love.  One of the most challenging aspects of conducting research in this space is that while the plants are legal, it is not legal to make any medical claims until they can be proven to Health Canada in clinical trials.

I’m allowed to grow and sell peyote, but I can’t make specific claims about what medical properties I’m seeing in my research.  I find this frustrating at times, but the alternative is the marketplace of yesteryear, where snake oil salesmen can misrepresent medical products.

What’s your vision of the industry in 20 years?

Purchase Lasix Pills

I think that the new psychedelic movement will continue to revolutionize how we treat depression, OCD, PTSD, and substance abuse. There will also be greatly expanded use among people without health problems, who are seeking improved athletics, sex, sleep, and creativity.   Perhaps most exciting, I think that psychedelics will help to bridge the gap between spirituality and scientific study.

I’m a scientist to my core, and I believe that the phenomenon that people experience as expanded consciousness is real.  Most spiritual phenomena are next to impossible to study scientifically because they can not easily be repeated.  The chemically triggered nature of spiritual experiences from psychedelics offers the scientific community a chance to study this most elusive phenomenon. We are living in the golden age of psychedelic research. In 20 years, we will have a much deeper scientific understanding of the underlying mechanisms responsible for the feeling of connectedness associated with these experiences.

What are your biggest worries for the industry?

I worry that with all of the excitement around mushrooms, scientists and the broader psychedelic movement will continue to more or less ignore peyote.  Peyote is arguable the most powerful of all plant medicines.  It contains 50+ active chemicals we know almost nothing about.  It has played an outsized role in the history of psychedelics.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Because it is a threatened species in the wild, and an important religious sacrament, it has become taboo to study.  I completely understand why, but I believe this is hurting the effort to preserve the species, and greatly impeding scientific progress. 10 years ago, CBD was a little-known and understudied chemical. Research into the lesser-known chemicals in the cannabis entourage has led to countless people benefiting.  I’m convinced there is every bit as much potential in the peyote entourage.

Who are your heroes?

There has long been a powerful social stigma preventing some people from exploring psychedelics.  Five years ago, I could never have imagined that so many “square” people would entertain the idea. The trend of microdosing has allowed many people to rethink psychedelics, and that shows a level of maturity that I did not think was there.  In such a divisive and polarizing time, we don’t often hear about people changing their minds. Being sincerely open to radically new ideas makes you a hero in my book.

If you could create a psychedelic to do anything you wanted, what would it do?

9 years ago, I was one of the first people to go on national television and demonstrate that CBD can treat pediatric epilepsy.  CBD has now been proven by mainstream science to work, but the reason why remains unproven.  A few years later, a new discovery suggested that the explanation may also explain why some cannabis can improve sexual experiences.  For both, the underlying mechanism appears to be rooted in rhythmic entrainment.

Rhythmic entrainment also appears to play an important role in the experience of connectedness that is associated with some psychedelics.  It’s that sense of connectedness that interests me most. It can take many forms, but I see them as one and the same.  Whether it is from sharing music among friends, a spiritual epiphany,  intense sexual experiences, meditation, or whatever else.  It is that phenomenon where people experience a profound sense of connectedness that I want to share with the world, with the help of science and peyote.

 

We’d like to thank Nathaniel for being a part of the Psychedelic Titans series. Stay tuned for more profiles on leaders in the psychedelic industry.

Would you like to participate in this series? Fill out this form and we’ll follow up with a review of your application.

Tags: Peyote Lab
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
CEO Interview: Journey Colab

CEO Interview: Journey Colab

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.